A HIF-2α inhibitor
Related Products
Isomer(s)
21325PT2385
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Belzutifan

Item No. 39652

Technical Information
Formal Name
3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro-benzonitrile
CAS Number
1672668-24-4
Synonyms
  • MK-6482
  • PT2977
Molecular Formula
C17H12F3NO4S
Formula Weight
Purity
≥98%
A solid
Acetonitrile: SolubleDMSO: Soluble
SMILES
CS(=O)(C1=C2C([C@H]([C@H]([C@H]2O)F)F)=C(C=C1)OC3=CC(F)=CC(C#N)=C3)=O
InChi Code
InChI=1S/C17H12F3NO4S/c1-26(23,24)12-3-2-11(13-14(12)17(22)16(20)15(13)19)25-10-5-8(7-21)4-9(18)6-10/h2-6,15-17,22H,1H3/t15-,16-,17+/m1/s1
InChi Key
LOMMPXLFBTZENJ-ZACQAIPSSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Belzutifan is an inhibitor of hypoxia-inducible factor-2α (HIF-2α).1,2 It inhibits HIF-2α heterodimerization with the aryl hydrocarbon receptor nuclear translocator (ARNT) PAS-B domain in a cell-free assay (Ki = 23 nM), activation of HIF-2α in a reporter assay using 786-O renal cell carcinoma cells (IC50 = 17 nM), and secretion of the HIF-2α target VEGF-A from 786-O cells (EC50 = 17 nM). Belzutifan (0.3-3 mg/kg) induces tumor regression in a 786-O mouse xenograft model.2 It reduces hematocrit levels and right ventricular pressure in mice expressing an arginine-to-tryptophan mutation at position 200 in the von Hippel-Lindau protein (VHLR200W) in a model of Chuvash polycythemia when administered at a dose of 0.1 mg/g.3 Formulations containing belzutifan have been used in the treatment of VHL disease-associated cancers.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ren, X., Diao, X., Zhuang, J., et alStructural basis for the allosteric inhibition of hypoxia-inducible factor 2 by belzutifan. Mol. Pharmacol. MOLPHARM-AR-2022-000525, (2022).

    2. Xu, R., Wang, K., Rizzi, J.P., et al3-[(1 S,2 S,3 R)-2,3-difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a hypoxia-inducible factor 2α (HIF-2α) inhibitor for the treatment of clear cell renal cell carcinoma. J. Med. Chem. 62(15), 6876-6893 (2019).

    3. Ghosh, M.C., Zhang, D.-L., Ollivierre, W.H., et alTherapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases. Blood 137(18), 2509-2519 (2021).